Template:Emtricitabine rilpivirine tenofovir: Difference between revisions

Latest revision as of 05:21, 10 January 2014

Emtricitabine rilpivirine tenofovir
COMPLERA^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

@@ Line 21: / Line 21: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Emtricitabine rilpivirine tenofovir overdosage|Overdosage]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Emtricitabine rilpivirine tenofovir clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Emtricitabine rilpivirine tenofovir dosage and administration|Dosage and Administration]]